This article is freely available to all

Abstract

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We read with interest the recently published discussion concerning the primary care setting.1 The role of resperidone and olanzapine in managing the adverse behavioral manifestations of dementia, including agression and other behavioral dyscontrol problems, was of particular interest. We were appreciative of the emphasis placed upon judicious use of low doses of these medications and the emergence of significant side effects such as falls and somnolence at very low doses of resperidone in particular.